Rulings protect generic drugmakers and overturn data-mining ban

06/23/2011 | New York Times (tiered subscription model), The

The Supreme Court handed down a pair of decisions that represent a significant victory for the pharmaceutical industry. A 5-4 ruling shields generic drugmakers from failure-to-warn lawsuits as long as their product labels are identical to those of brand-name drugmakers. A 6-3 decision strikes down a law in Vermont restricting the collection and sale of prescription-drug data.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC